Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of metachronous advanced colorectal neoplasia by KRAS mutation in polyps.
Martínez-Roca A, Cubiella J, García-Heredia A, Guill-Berbegal D, Baile-Maxía S, Mangas-Sanjuán C, Sala-Miquel N, Madero-Velazquez L, Alenda C, Zapater P, González-Núñez C, Iglesias-Gómez A, Codesido-Prado L, Díez-Martín A, Kaminski MF, Erichsen R, Adami HO, Ferlitsch M, Pellisé M, Holme Ø, Dekker E, Bretthauer M, Jover R; EPoS Study Group. Martínez-Roca A, et al. Among authors: madero velazquez l. United European Gastroenterol J. 2024 Nov;12(9):1179-1189. doi: 10.1002/ueg2.12667. Epub 2024 Oct 13. United European Gastroenterol J. 2024. PMID: 39400528 Free PMC article.
Inhibin B and antiMüllerian hormone as surrogate markers of fertility in male and female Crohn's disease patients: a case-control study.
Gutiérrez A, Muñoz-Pérez R, Zapater P, Mira C, Rodríguez A, Sempere-Robles L, Torregrosa ME, Alfayate R, Moreno-Torres V, Bernal L, Belén-Galipienso O, Cameo JI, Sirera P, Herreros B, Bernabeu P, Moreno-Pérez O, Madero-Velázquez L. Gutiérrez A, et al. Among authors: madero velazquez l. Front Med (Lausanne). 2024 Apr 25;11:1374603. doi: 10.3389/fmed.2024.1374603. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38725465 Free PMC article.
Psychological burden and quality of life in newly diagnosed inflammatory bowel disease patients.
Bernabeu P, Belén-Galipienso O, van-der Hofstadt C, Gutiérrez A, Madero-Velázquez L, García Del Castillo G, García-Sepulcre MF, Aguas M, Zapater P, Rodríguez-Marín J, Ruiz-Cantero MT, Cameo JI, Jover R, Sempere L. Bernabeu P, et al. Among authors: madero velazquez l. Front Psychol. 2024 Jan 29;15:1334308. doi: 10.3389/fpsyg.2024.1334308. eCollection 2024. Front Psychol. 2024. PMID: 38348263 Free PMC article.
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, Gisbert JP, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: madero velazquez l. Gastroenterol Hepatol. 2024 Aug-Sep;47(7):750-758. doi: 10.1016/j.gastrohep.2023.12.012. Epub 2024 Jan 12. Gastroenterol Hepatol. 2024. PMID: 38219960 English, Spanish.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Casas Deza D, Julián Gomara AB, Caudevilla Biota E, Beltrán B, Domènech E, Gutiérrez Casbas A, Mañosa M, Zabana Y, Roc Alfaro L, Valverde Romero E, García González E, Sicilia B, Laredo V, Alcalá Escriche MJ, Madero Velázquez L, Ferreiro-Iglesias R, Palmero Pérez A, Calafat M, Rubio Iturria S, Moraleja Yudego I, Ber Nieto Y, García Mateo S, Gisbert JP, Vicente Lidón R, Arias L, Alfambra E, Doñate Borao AB, Peña González E, Corsino Roche P, Vicuña Arregui M, Elorza A, Domínguez Cajal M, Chaparro M, Barreiro-de Acosta M, García-López S. Casas Deza D, et al. Among authors: madero velazquez l. Gastroenterol Hepatol. 2024 Oct;47(8):821-833. doi: 10.1016/j.gastrohep.2023.11.004. Epub 2023 Nov 23. Gastroenterol Hepatol. 2024. PMID: 38007154 English, Spanish.
Inflammatory bowel disease new-onset during secukinumab therapy: real-world data from a tertiary center.
Ojeda Gómez A, Madero Velázquez L, Buendía Sanchez L, Pascual Sánchez I, Pérez Rabasco E, García Monsalve A, González Ferrández JA, García Sepulcre MF. Ojeda Gómez A, et al. Among authors: madero velazquez l. Rev Esp Enferm Dig. 2021 Dec;113(12):858-859. doi: 10.17235/reed.2021.8397/2021. Rev Esp Enferm Dig. 2021. PMID: 34696593 Free article.
What are the odds? Duodenum adenocarcinoma as a primary metachronic neoplasia.
Ojeda Gómez A, Íñigo Chaves AM, Barragán Martínez J, Madero Velázquez L, Picó Sala MD, García Soria A, Sáez Fuster J, García Sepulcre MF. Ojeda Gómez A, et al. Among authors: madero velazquez l. Rev Esp Enferm Dig. 2021 Nov;113(11):793-794. doi: 10.17235/reed.2021.8200/2021. Rev Esp Enferm Dig. 2021. PMID: 34320812 Free article.
Duodenal schwannoma, an infrequent entity.
Madero Velázquez L, Uceda F, Buendía L. Madero Velázquez L, et al. Rev Esp Enferm Dig. 2021 Jul;113(7):548-549. doi: 10.17235/reed.2020.7371/2020. Rev Esp Enferm Dig. 2021. PMID: 33244978 Free article.